The Board proposes the promulgation of a new rule to implement s. 465.189, F.S., by authorizing the administration of vaccines or immunizations contained in the CDC Adult Immunization Schedule as revised subsequent to the 2015 edition.  

  •  

    DEPARTMENT OF HEALTH

    Board of Pharmacy

    RULE NO.:RULE TITLE:

    64B16-27.630Additional Immunizations or Vaccines Which May Be Administered.

    PURPOSE AND EFFECT: The Board proposes the promulgation of a new rule to implement s. 465.189, F.S., by authorizing the administration of vaccines or immunizations contained in the CDC Adult Immunization Schedule as revised subsequent to the 2015 edition.

    SUMMARY: The creation of this new rule will implement s. 465.189, F.S., by authorizing the administration of vaccines or immunizations contained in the CDC Adult Immunization Schedule as revised subsequent to the 2015 edition.

    SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION: The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

    The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

    Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

    RULEMAKING AUTHORITY: 465.005, 465.189 FS.

    LAW IMPLEMENTED: 465.189 FS.

    IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Allison Dudley, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254

     

    THE FULL TEXT OF THE PROPOSED RULE IS:

     

    64B16-27.630 Additional Immunizations or Vaccines Which May Be Administered.

    In addition to the immunizations or vaccines listed in the United States Centers for Disease Control and Prevention Adult Immunization Schedule as of February 1, 2015, the Board hereby authorizes administration of the following additional immunizations or vaccines by persons certified pursuant to section 465.189, F.S.

    Meningococcal B (MemB).

    Rulemaking Authority 465.005, 465.189 FS.  Law Implemented 465.189 FS. History–New __________.

     

    NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy

    NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Pharmacy

    DATE PROPOSED RULE APPROVED BY AGENCY HEAD: April 5, 2016

    DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: May 3, 2016

Document Information

Comments Open:
5/19/2016
Summary:
The creation of this new rule will implement s. 465.189, F.S., by authorizing the administration of vaccines or immunizations contained in the CDC Adult Immunization Schedule as revised subsequent to the 2015 edition.
Purpose:
The Board proposes the promulgation of a new rule to implement s. 465.189, F.S., by authorizing the administration of vaccines or immunizations contained in the CDC Adult Immunization Schedule as revised subsequent to the 2015 edition.
Rulemaking Authority:
465.005, 465.189 FS.
Law:
465.189 FS.
Contact:
Allison Dudley, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254.
Related Rules: (1)
64B16-27.630.